Cargando…

Severe community-acquired pneumonia in the intensive care unit

Detalles Bibliográficos
Autores principales:	Costa, C, Gouveia, I, Cunha, P, Milheiro, R, Bártolo, A, Gonçalves, C, Carvalho, A, Cardoso, T, Martins, S, Magalhães, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226134/ https://www.ncbi.nlm.nih.gov/pubmed/15836778 http://dx.doi.org/10.1186/cc3064

Ejemplares similares

Pre-eclampsia in the intensive care unit: indicators of severity and hospital outcome
por: Gouveia, I, et al.
Publicado: (2005)

Epidemiology of community-acquired bacteremia patients admitted to the intensive care unit
por: Castro, Guiomar, et al.
Publicado: (2007)

Organophosphate poisoning and related mortality with oxime perfusion
por: Bartolo, A, et al.
Publicado: (2007)

Community-acquired pneumonia treated on the ICU
por: Apostolidou, E, et al.
Publicado: (2006)

Community-acquired bacteraemia with sepsis in adults admitted to the intensive care unit: a prospective multicentre study
por: Cardoso, Teresa, et al.
Publicado: (2007)

The current pathogens and treatment of hospital-acquired pneumonia/ventilator-associated pneumonia in medical intensive care units
por: Chang, Y, et al.
Publicado: (2015)

Use of statins in community-acquired pneumonia in intensive care settings: is there a survival advantage?
por: Khanna, A, et al.
Publicado: (2011)

Outcome of severe community-acquired pneumonia: the impact of comorbidities
por: Pereira, JM, et al.
Publicado: (2013)

Severe community-acquired pneumonia: risk factors for in-hospital mortality
por: Pereira, JM, et al.
Publicado: (2012)

Middle molecules in severe community-acquired pneumonia
por: Dumitras, T, et al.
Publicado: (2015)

Comparison of levofloxacin (L) and cefotaxime (C) combined with ofloxacin (O) for treatment of severe community-acquired pneumonia (CAP) in the intensive care unit
por: Leroy, O, et al.
Publicado: (2004)

Respiratory community-acquired and healthcare-related sepsis: are they different?
por: Castro, G, et al.
Publicado: (2008)

Host genetic variants associated with community-acquired pneumonia
por: Salnikova, LE, et al.
Publicado: (2013)

Systemic corticosteroids for community-acquired pneumonia in adults
por: Pugh, RJ, et al.
Publicado: (2012)

Mathematical modeling of community-acquired pneumonia patients
por: Sarkar, J, et al.
Publicado: (2009)

Prognostic assessment in community-acquired pneumonia by pneumonia severity scores and biomarkers
por: Dusemund, F, et al.
Publicado: (2010)

Community-acquired and healthcare-related urosepsis: a multicenter prospective study
por: Cardoso, T, et al.
Publicado: (2008)

Validation of predictive rules for ICU patients with community-acquired pneumonia
por: Rudnov, V, et al.
Publicado: (2008)

Timing of admissions and outcome of pneumonia in intensive care units in the United Kingdom
por: Boralessa, H, et al.
Publicado: (2007)

Racial disparities in quality of care in community-acquired pneumonia
por: Mayr, FB, et al.
Publicado: (2008)

Surveillance of ICU-acquired infections: intensive care unit characteristics, practices in prevention and surveillance methodology
por: Morales, I, et al.
Publicado: (2005)

Severity of illness scoring systems in community-acquired Legionella pneumonia
por: Simonsen, Ø, et al.
Publicado: (2010)

Analysis of the mortality rate in patients admitted to the ICU for severe community-acquired pneumonia
por: Joya-Montosa, C, et al.
Publicado: (2015)

Defining severe community-acquired pneumonia: a significant barrier to improving patient outcomes
por: Balp, MM, et al.
Publicado: (2009)

Pre-analytic factors and initial biomarker levels in community- acquired pneumonia patients
por: Kutz, A, et al.
Publicado: (2014)

Enteral nutrition on intensive care unit: a protocol based approach
por: Jesus, G, et al.
Publicado: (2015)

Effects of systemic steroid in patients with severe community-acquired pneumonia requiring mechanical ventilation
por: Chon, G, et al.
Publicado: (2009)

Assessment of specific risk scores for patients admitted to the ICU for severe community-acquired pneumonia
por: Joya-Montosa, C, et al.
Publicado: (2015)

A new severity score for community-acquired pneumonia: PARB score
por: Uchiyama, N, et al.
Publicado: (2010)

Criteria of the systemic inflammatory response syndrome in patients with community-acquired pneumonia
por: Ustyantseva, I, et al.
Publicado: (2006)

Coagulation in hospitalized community-acquired pneumonia: disturbances in even the least ill
por: Reade, MC, et al.
Publicado: (2008)

Association of C-Reactive Protein and Outcome in Patients With Community-Acquired Pneumonia
por: Park, JK, et al.
Publicado: (2015)

Portuguese network data: epidemiology of community-acquired sepsis
por: Carneiro, A, et al.
Publicado: (2006)

Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia
por: Suberviola, B, et al.
Publicado: (2011)

Glycemic variability as a risk factor of intensive care unit-acquired weakness
por: Mörgeli, R, et al.
Publicado: (2015)

Procalcitonin guidance significantly reduces antibiotic duration in community-acquired pneumonia: the 'ProCAP' study
por: Christ-Crain, M, et al.
Publicado: (2005)

Simple and fast prediction of Legionella sp. in community-acquired pneumonia: validation of a prediction rule
por: Haubitz, S, et al.
Publicado: (2013)

Severe pneumonia in critically ill cancer patients: clinical outcomes and a comparison between healthcare-associated pneumonia and community-acquired pneumonia
por: Rabello, Ligia SCF, et al.
Publicado: (2013)

Beneficial effects of antiplatelet drugs in patients with community-acquired pneumonia and in endotoxin shock in mice
por: Winning, J, et al.
Publicado: (2007)

Community-acquired pneumonia: a comparison of clinical treatment failure in patients treated with either penicillin or cefuroxime
por: Ekloef, Josefin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_63q9o7fmdpfmc6dcv8bc009pfl